Slowing the spread of malaria drug resistance by extending the lifespan of the artemisinin derivatives

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1100394

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Approximately 200 million clinical cases of malaria are treated globally each year. Alarmingly, resistance to the most highly effective antimalarial drugs, has emerged in Southeast Asia, jeopardizing malaria control. This project will develop novel mathematical models that predict the action of the antimalarial drug within an infected individual to inform the malaria community of optimal treatment strategies in areas where resistance has emerged.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $391,518.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biostatistics | infectious diseases | malaria drug resistance | malaria therapy | mathematical modelling

Related Links